The expression levels of AC062021.1, SNHG6, LINC00507, FAM66C, DGCR10, and LINC00641 were significantly lower in glioma tissues than in normal brain tissues (P < .05) and gradually increased with the degree of malignancy. Here, FAM66C is linked to central nervous system cancer.